Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy with or without hepatic perfusion for metastatic colorectal cancer
NCT00020501Phase 3Completed
- Sponsor
- National Institutes of Health
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melphalan in metastatic colorectal cancer (mCRC), sponsored by National Institutes of Health. Started Mar 2001; status: completed.
02
Drugs
melphalan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00020501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020501.